• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

节段性肿瘤切除术后胫骨近端骨骺超短柄固定:4例患者平均随访56个月的重建存活情况分析

Ultra-short stem anchorage in the proximal tibial epiphysis after intercalary tumor resections: analysis of reconstruction survival in four patients at a mean follow-up of 56 months.

作者信息

Guder W K, Hardes J, Gosheger G, Nottrott M, Streitbürger A

机构信息

Department of Orthopedics and Tumor Orthopedics, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany.

出版信息

Arch Orthop Trauma Surg. 2017 Apr;137(4):481-488. doi: 10.1007/s00402-017-2637-7. Epub 2017 Feb 17.

DOI:10.1007/s00402-017-2637-7
PMID:28213847
Abstract

INTRODUCTION

Tumors localized in the proximal tibial meta-diaphysis often lead to osteoarticular resections.

MATERIALS AND METHODS

In this study, we retrospectively reviewed four patients who underwent intercalary tumor resection and reconstruction using an ultra-short stem in the proximal tibial epiphysis, a procedure that to our knowledge has not been reported in literature so far.

RESULTS

At the time of operation, the mean patient age was 26.2 years. Three patients were male and one was female. Patients were diagnosed with osteosarcoma in two cases, Ewing's sarcoma and malignant fibrous histiocytoma of bone in one case each. In all cases, wide tumor resections were achieved (osteotomy 3-3.5 cm below the tibia plateau joint surface, mean resection length of tibial bone 18 cm) at a mean time of operation of 198.8 min. Two superficial wound-healing disorders occurred, leading to one surgical revision in each case. One local tumor recurrence occurred 12 months after operation in a patient who discontinued his adjuvant chemotherapy. This patient died of disease, 31 months after operation. Three patients are alive with no evidence of disease at a mean follow-up of 56 months. Walking is not impaired and light sports activities have been reported in all cases. The mean MSTS score is 28/30.

CONCLUSIONS

Therefore, we report this reconstruction technique to be considered for special indications where the functional outcome can be improved by preservation of the knee joint in tumors of the proximal meta-diaphyseal tibial region.

摘要

引言

位于胫骨近端干骺端的肿瘤常导致骨关节切除。

材料与方法

在本研究中,我们回顾性分析了4例接受胫骨近端骨骺间置肿瘤切除并使用超短柄进行重建的患者,据我们所知,该手术目前尚未见文献报道。

结果

手术时患者平均年龄为26.2岁。3例为男性,1例为女性。2例患者诊断为骨肉瘤,1例为尤因肉瘤,1例为骨恶性纤维组织细胞瘤。所有病例均实现了广泛的肿瘤切除(在胫骨平台关节面下方3 - 3.5 cm处截骨,胫骨平均切除长度为18 cm),平均手术时间为198.8分钟。发生了2例表浅伤口愈合障碍,均进行了1次手术翻修。1例患者在停止辅助化疗后于术后12个月出现局部肿瘤复发。该患者于术后31个月死于疾病。3例患者存活,平均随访56个月时无疾病证据。行走未受影响,所有病例均报告可进行轻度体育活动。平均MSTS评分为28/30。

结论

因此,我们报告了这种重建技术,对于胫骨近端干骺端区域肿瘤,在某些特殊情况下,通过保留膝关节可改善功能结局,该技术值得考虑应用。

相似文献

1
Ultra-short stem anchorage in the proximal tibial epiphysis after intercalary tumor resections: analysis of reconstruction survival in four patients at a mean follow-up of 56 months.节段性肿瘤切除术后胫骨近端骨骺超短柄固定:4例患者平均随访56个月的重建存活情况分析
Arch Orthop Trauma Surg. 2017 Apr;137(4):481-488. doi: 10.1007/s00402-017-2637-7. Epub 2017 Feb 17.
2
Intercalary Resection of the Tibia for Primary Bone Tumors: Are Vascularized Fibula Autografts With or Without Allografts a Durable Reconstruction?胫骨中间段切除治疗原发性骨肿瘤:带血管腓骨自体骨移植联合或不联合异体骨移植是否能实现持久重建?
Clin Orthop Relat Res. 2024 Mar 21;482(6):960-75. doi: 10.1097/CORR.0000000000003007.
3
Survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee.膝关节骨肉瘤骨骺保留与同种异体骨移植重建后的生存、复发及功能情况
Clin Orthop Relat Res. 2015 May;473(5):1789-96. doi: 10.1007/s11999-014-4028-5. Epub 2014 Oct 29.
4
Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee.膝关节高级别干骺端骨肉瘤的部分骨骺保留与节段性同种异体骨移植重建
J Bone Joint Surg Am. 2004 Dec;86(12):2686-93. doi: 10.2106/00004623-200412000-00015.
5
What Are the Complications of Allograft Reconstructions for Sarcoma Resection in Children Younger Than 10 Years at Long-term Followup?异体骨重建治疗 10 岁以下儿童肉瘤切除术后的长期随访并发症有哪些?
Clin Orthop Relat Res. 2018 Mar;476(3):548-555. doi: 10.1007/s11999.0000000000000055.
6
Epiphysis preserving resection of malignant proximal tibial tumours.保骺板切除术治疗胫骨近端恶性骨肿瘤。
Int Orthop. 2013 Jan;37(1):99-104. doi: 10.1007/s00264-012-1731-2. Epub 2012 Dec 7.
7
Do Massive Allograft Reconstructions for Tumors of the Femur and Tibia Survive 10 or More Years after Implantation?异体骨大段重建股骨和胫骨肿瘤,植入后 10 年以上存活率如何?
Clin Orthop Relat Res. 2020 Mar;478(3):517-524. doi: 10.1097/CORR.0000000000000806.
8
Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee.膝关节高级别干骺端骨肉瘤的部分骨骺保留及节段性同种异体骨移植重建
J Bone Joint Surg Am. 2005 Sep;87 Suppl 1(Pt 2):226-36. doi: 10.2106/JBJS.E.00253.
9
Is There Benefit to Free Over Pedicled Vascularized Grafts in Augmenting Tibial Intercalary Allograft Constructs?在增强胫骨节段性同种异体移植结构方面,游离血管化移植物相对于带蒂血管化移植物有优势吗?
Clin Orthop Relat Res. 2017 May;475(5):1322-1337. doi: 10.1007/s11999-016-5196-2. Epub 2016 Dec 19.
10
Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus.模块化可插入式人工关节置换治疗股骨、胫骨和肱骨节段性骨缺损的疗效
Clin Orthop Relat Res. 2016 Feb;474(2):539-48. doi: 10.1007/s11999-015-4588-z.

引用本文的文献

1
Intercalary Diaphyseal Endoprosthetic Reconstruction.干骺端中间型人工关节置换重建术
J Am Acad Orthop Surg Glob Res Rev. 2025 Jul 2;9(7). doi: 10.5435/JAAOSGlobal-D-24-00201. eCollection 2025 Jul 1.
2
Ultra-short stem intercalary prosthetic reconstruction for joint preservation in metaphyseal tumor management: a retrospective review of twenty-five cases.超短柄节段性假体重建在干骺端肿瘤保关节治疗中的应用:25例回顾性分析
BMC Musculoskelet Disord. 2025 May 24;26(1):513. doi: 10.1186/s12891-025-08780-z.
3
Knee-Sparing Resection and Reconstruction Surgery for Bone Sarcoma Using 3D-Surgical Approach: Average of 5-Year Follow-Up.
采用三维手术方法进行骨肉瘤保膝切除与重建手术:平均5年随访
Medicina (Kaunas). 2025 Mar 8;61(3):476. doi: 10.3390/medicina61030476.
4
Utilization of 3D-Printed Customized Uncemented Stem Prostheses for Revision of Aseptic Loosening in the Distal Femoral Cemented Prostheses: Case Series and Literature Review.利用3D打印定制非骨水泥型股骨柄假体翻修股骨远端骨水泥型假体无菌性松动:病例系列及文献综述
Orthop Surg. 2025 Mar;17(3):801-813. doi: 10.1111/os.14331. Epub 2024 Dec 23.
5
A novel non-invasive electromagnetic extendable intercalary endoprosthesis: a proof-of-concept study.一种新型非侵入性电磁可扩展中间内置假体:概念验证研究。
Front Bioeng Biotechnol. 2024 Jul 18;12:1400428. doi: 10.3389/fbioe.2024.1400428. eCollection 2024.
6
Intercalary Prosthetic Reconstruction with Three-Dimensional-Printed Custom-Made Porous Component for Defects of Long Bones with Short Residual Bone Segments After Tumor Resection.肿瘤切除后骨缺损伴有短残骨段的长骨的三维打印定制多孔构件间置式假体重建。
Orthop Surg. 2024 Feb;16(2):374-382. doi: 10.1111/os.13969. Epub 2023 Dec 18.
7
[Research progress of cementless intercalary prosthesis stem].[非骨水泥型间置假体柄的研究进展]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 May 15;36(5):643-647. doi: 10.7507/1002-1892.202112067.
8
Is three-dimensional-printed custom-made ultra-short stem with a porous structure an acceptable reconstructive alternative in peri-knee metaphysis for the tumorous bone defect?三维打印的定制超短多孔结构干骺端假体在膝关节周围骨肿瘤骨缺损的重建中是否可接受?
World J Surg Oncol. 2021 Aug 8;19(1):235. doi: 10.1186/s12957-021-02355-7.
9
Reconstruction survival of segmental megaendoprostheses: a retrospective analysis of 28 patients treated for intercalary bone defects after musculoskeletal tumor resections.节段性大块假体重建的存活率:28 例因肌肉骨骼肿瘤切除后骨缺损而接受间插骨缺损治疗的患者的回顾性分析。
Arch Orthop Trauma Surg. 2022 Jan;142(1):41-56. doi: 10.1007/s00402-020-03583-4. Epub 2020 Aug 29.
10
Intercalary Reconstruction of the "Ultra-Critical Sized Bone Defect" by 3D-Printed Porous Prosthesis After Resection of Tibial Malignant Tumor.胫骨恶性肿瘤切除术后3D打印多孔假体对“超临界尺寸骨缺损”的间置重建
Cancer Manag Res. 2020 Apr 8;12:2503-2512. doi: 10.2147/CMAR.S245949. eCollection 2020.